Prof. Dr Mike Chan
Prof. Dr Mike Chan
Senior Technical Consultant
Prof. Dato’ Sri Dr. Mike K.S. Chan, is a Researcher, Author, Educator and an Entrepreneur in the specialised fields of Biotechnology Research & Development of Stem Cells and Peptide Therapeutics and Biological & Regenerative Medicine for multiple corporations globally. He is also the co-Owner & Founder of the European Wellness Biomedical Group, Germany, a vertically-integrated group comprising key divisions in IP Research & Development, Biotech & BioPharma Manufacturing Plants (Germany & EU), Educational Institutions & Professional Academies, Global Product Distribution across 80 countries, and 26 medical wellness, diagnostics and youth restorative centres in Europe and Asia Pacific including Switzerland, Germany, Greece, China, Hong Kong, Malaysia, Thailand, Philippines, Mexico, Vietnam, Cambodia, Laos, and Bangladesh with VIP clientele comprising Presidents, Head of States, Hollywood, Hong Kong and Chinese Celebrities and the Rich & Famous.
He is an Author/co-Author of over 20 scientific books on Stem Cells (including for animals), Aging, Neurodegenerative & Neurodevelopment Disorders, Metabolic Diseases, Biological & Regenerative Medicine and over 50 scientific and medical publications in USA and UK. He is also a recipient of multiple international awards for Biotechnology in Europe and Middle East. He also holds multiple international patents worldwide for a number of biopharmaceuticals including stem cells, peptides, autoimmune therapies and parenteral nutrition.
Since the mid-80s with humble beginning of a seed capital of USD10,000, Mike had first-hand experience being under the tutelage of some of the world’s greatest cell therapists hailing from the Soviet Union, Germany & Switzerland. Mike subsequently pioneered bio-regenerative medicine, cellular/organo therapy, and stem cell research in Europe, and thereafter led a number of Swiss and German companies renowned for anti-aging cellular therapies into rapid global expansion, with diverse operations from R&D and product development, to manufacturing and distribution, and subsequently physician education initiatives to improve clinical applications of the biopharmaceuticals.
Also renowned for being the pioneer for first introducing stem cell research and cellular therapy into Asia Pacific in the mid 80’s, Mike has since initiated educational programs for physicians and agents from his extensive product distribution networks across 80 countries. A frequent public speaker, he has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the field of biotech sciences, biopharmaceuticals, anti-aging, regenerative medicine, and stem cell therapies.
Mike Chan currently sits on the Board and is the Head of the Regenerative Medicine Scientific Committee for Europe’s largest preventative, regenerative and anti-aging scientific body, ESAAM (European Society of Preventative, Regenerative and Anti-Aging Medicine) established in 2003 and is also the Society’s Asian Chairman. He is also an Associate Professor of AASCP, USA (American Academy of Stem Cell Physicians), Chairman for A4M, USA (American Academy of Anti-Aging Medicine) for Thailand/Asia, Japan’s Regenerative Medical Association MMJ (Multi-Dimensional Holistic Medical Team Japan) and co-Founder of FCTI Precursor Stem Cells, Europe. In 2018 and 2019, together with his team of clinicians, he has brought significant Medical and Wellness Tourism and Education Tourism into Switzerland, Germany and Malaysia with physicians from USA, Portugal, Belgium, China, Spain, UK, Indonesia, Thailand, Singapore, Vietnam, Philippine, and Middle East.
He is also a Senator of BWA, Germany (Federal Association for Economic Development & Foreign Trade for China, Indonesia & Malaysia). He spearheads, hires, and works in collaboration with top scientists and scholars worldwide from MIT, Oxford, Cambridge Heidelberg University and University of Irvine, California etc. He has won numerous awards (17), for top leadership, entrepreneurship, quality assurance and achievement awards from Europe to China. He holds membership in more than 20 academic bodies and associations.
Residing in Kota Kinabalu, Sabah, and Europe for more than three decades, it has always been his aspiration as a proud Malaysian Chinese of ‘Budak Kampung’ origin where he is a third generation of Chinese Fujian origin to bring World-Class, Cutting-Edge Biotechnology, Research & Education to Malaysia and China. He is currently working with the Chinese Shandong Government on Biotechnology, Educational & Research Centers on Biological/Regenerative Medicine & Sport Injury and Rehabilitation and has been an invited expert speaker on stem cells and nutrition for Covid (including Covid Pandemic, Feb 14, 2020) by Chinese authorities on numerous occasions in China.
MULTIPLE TRADEMARKS AND PATENT HOLDER FOR TECHNOLOGY:
Holds several International Patents for Stem Cells and Peptides, Immunology, Auto Immune & Formulation Technologies in Switzerland, Germany, Europe, USA, and Malaysia including:
PROFESSIONAL MEMBERSHIP Of The Scientific Committee & Other Professional Clubs Of The Following Non-Profitable Organizations:
MULTIPLE INTERNATIONAL INVENTION AWARDS RECIPIENT AND WINNER, Including:
CURRENT PROJECTS, Includes:
Prof Dr Mike Chan share his 35yrs of experience on stem cell therapy on biological age reversal
SIMILIA SIMILIBUS CURANTUR
I have always been drawn to cell therapy due to the principal “Like treats like”, from the latin “similia similibus curantur” – liver to liver, heart to heart, kidney to kidney. The human body is dependent on the integrity of the system and we now know that disease comes primarily from our own system. The system depends on the organs and the organs depend on the cells. At the end of the day as our cells age, so we also age.
We have something in the order of 37.2 trillion cells when we are born, amongst those cells we have about 1 stem cell in every 10,000. As we age that number decreases steadily until by the time we die will have zero stem cells. We cannot stop aging but with cellular therapy we can do a bit of reversing, thus delaying the aging process. It’s an exciting time in medical history to be able to provide these cell therapy services and delay the aging process and fight almost any disease, without the use of drugs.
Pioneered cellular therapy & stem cell research in Europe since 1980’s and spear headed a renowned Swiss and German company which was known for its anti-ageing, regenerative medicine and cellular therapies. Initiated educational programs for physicians and distribution networks in more than 80 countries. One of the world’s influential researcher, developer and providers of Swiss German & European cellular therapy products in the field of anti-aging, regenerative, nutritional and biological medicine at its height. He was probably one of the ‘first’ to introduce cellular therapy, bio molecular medicine in the 80’s and stem cell research to Asia in the early 90’s.
Ex-co-founder and ex-owner of the LD Suisse Group (1992 to 2014) with then more than 600 permanent professional staff worldwide, a Swiss based HQ in Geneva with Clinics in Lustmuhle, Lugano, Frankfurt and various parts of the world. LD Suisse Group also have an established multinational Asia Pacific Hub with more than 250 specialised tertiary staff in Kota Kinabalu, Sabah, Malaysia with a work force drawn from more than 10 nationalities in UK, Russia, Germany, USA, Australia, Hong Kong, China, Philippines, Bangkok, and a South American office in Ecuador.
Currently Founder and Chairman of the European Wellness Biomedical Group, Germany, with a chain of 26 International biological, intergrative and regenerative medical clinics of more than 1000 employees all over the world – including 3 in Switzerland (Lugano), Germany (Frankfurt) and Greece (Athens) with 22 others across China, Hong Kong, Malaysia, Thailand, Philippines, Vietnam, Cambodia, Pakistan, Bangladesh, UAE, etc.
The 26 hospitals, clinics and centers under his leadership are centers for revitalization, youth restoration, medical diagnostic & wellness antiaging programs which are popular among prominent VIP figures from America, Europe, the Middle East and Asia, including members of royalty, VIPs, celebrities and head of states.
Was one of the first Asian members in 2012 of the prestigious Leopard Club, an exclusive membership club comprising 200 of Switzerland’s most prominent business people including the 60 richest, bankers and the President of Switzerland.
Pioneered and introduced together with his wife and co-founder Professor Dr. Michelle Wong, Cellular Therapy & Biological Medicine across vast regions of the world in the Eighties and Stem Cell Therapies into Asia since 2002.
He steered a vast network of physicians across the Asia-Pacific region and led an international team of anti-aging doctors and professors to provide technical training programs in the region on precursor stem cell therapies and implantation methods. He is actively involved in pioneering industry research and development initiatives in the field of regenerative and biological medicine in Germany, Switzerland and Europe. Being a speaker himself, he has conducted – together with Professor Dr. Michelle Wong and the European medical team – more than 1000 lectures, seminars and symposiums worldwide across more than 65 regions in the field of anti-aging, regenerative medicine and stem cell therapies.
In 2021, Prof. Dato’ Sri Dr. Mike Chan was one of the select few to have received the highly-coveted Brand ICON Leadership Award during the BrandLaureate e-Branding Awards Gala Dinner – the highest honor awarded at the annual ceremony, a distinction offered to inspiring leaders whose success and contributions to various fields go above and beyond. He had also previously received the Most Outstanding Brands Leadership Award and spearheaded three companies (i.e., European Wellness, MF3, and FCTI) to earn individual awards during the 2020 BrandLaureate Awards. These awards have cemented his status as a global icon in bio-regenerative medicine, stem cells, and peptides – a testimony to Prof. Dato’ Sri Dr. Mike Chan’s continued efforts to be a trailblazer in these cutting-edge fields.
A book by Prof. Dr. Mike Chan and Prof. Dr. Yuriy Nalapko
Published by Matador, Troubador.co.uk, London – Medical Research: ISBN 978 1838592 509
Human Cell Membrane Therapy explores the theoretical and practical dimensions of improving service provision on majority of the diseases caused by cell damage. This readable and well-structured book is based on the reviews of current scientific publications on cellular membranes, its chemical structure and changes in many diseases. This monograph opens the new overview of the concepts of cell membranes therapy.
Detailed role of phosphatidylcholine as the principal component of the cell membranes is described. Among the important issues discussed are Parkinson’s and Alzheimer’s diseases, atherosclerosis, fatty liver disease, diabetes mellitus etc. The final chapter evaluated progress in the use of PlaqX – phosphatidylcholine-based substance, which is able to restore the cell membranes and provide significant health improvement. This detailed review and authors experience will be of value to anyone with an interest in the area of regenerative, biomolecular, and anti-aging medicine.
Professor Dato’ Sri Dr. Mike KS Chan is one of the pioneers of cellular and cell membrane therapy in Europe and Asia since the early 1980’s. He founded and spearheaded one of the world’s largest researches for bio-molecular medicine based in Switzerland and Germany with presence in almost 80 countries globally. He conducted more than 1,000 lectures, seminars and symposiums worldwide across more than 60 countries in the field of anti-aging, cell regeneration, regenerative medicine and stem cell therapies.
Dr. Yuriy Nalapko is academician and practical doctor in anesthesiology and intensive care. One of the areas of his scientific interests is longevity and a cell functioning in different diseases. His Philosophy Degree dissertation was devoted to the intensive care of brain injury patients. Last time he pays his attention to the cell membranes and the different methods of its structural and functional corrections. He considers the cell membrane therapy as the important component of the regenerative medicine and biomolecular therapy.
Published by Matador, Troubador.co.uk, London – Medical Research: ISBN 978 1838590 116
Author/s: Prof. Dr. Mike Chan and Prof. Dr. Dmitry Klokol
In most of the doctors’ perception the term ‘regenerative medicine’ is associated with tissue reconstruction after severe injuries, burns or trauma. And that is absolutely correct except the fact that tissues and organs deteriorate and lose their function not only due to mechanical or physical damage, but as a result of chronic diseases, inflammation, age-related degeneration as well as genetic abnormalities and cellular dysfunction. The profound understanding of tissue morphology on the cellular level and studying of the ontogenesis open magnificent opportunities to restoration of structural and functional integrity of human organism.
Throughout centuries scientists and healthcare practitioners were in a constant pursuit of longevity—from Avicenna and Paracelsus to Brown-Sequad, Serge Voronoff and Paul Niehans. Not so long ago, in 1990’s, when the term regenerative medicine was tailored by Dr. Leland Kaiser and propagated by William Haseltine it was considered to be a medicine of the Future, «a new branch of medicine will develop that attempts to change the course of chronic disease and in many instances will regenerate tired and failing organ systems», as Dr. Leland Kaiser described it. A new hope spurred up that almost any condition can be at least improved if not cured by means of regenerative medicine, including those cases where conventional medicine is powerless or ineffective.
The Future Dr. Kaiser was talking about is certainly a Present today. Though relatively small amount of practitioners are aware of today’s regenerative medicine capabilities and many still consider it more like science fiction.
This book reveals concepts and protocols of successful approach to regenerative medicine by means of stem cell therapy. It also highlights important aspects of manufacturing and culturing of cell therapy products and administration of different types of stem cells in various systemic disorders.
Published by Matador, Troubador.co.uk, London.Medical Research: ISBN 978 1789015 249
Author/s: Prof. Dr. Mike Chan and Prof. Dr. Dmitry Klokol
With the arise of chronic, age and lifestyle-related illnesses, overwhelming stress, toxins and pollution, the society began to value more aspects of personal health than mere physical symptoms – the balance and harmony of mind, spirit and body. The society came to realization that it is not enough to eliminate the symptoms of the disease or even to treat the core of the illness. In most of the cases, the end of hospital treatment of the disease is only the beginning of the actual struggle for the patient. Whatever considered to be an accomplished mission from the point of view of medical protocol is only the beginning of the battle for the patient, which he, often left alone, not necessarily wins.
Our experience in research and practice in various parts of Europe and Asia has brought us to conclusion that best definition for the term “biological medicine” is – “common sense medicine”. These therapeutic paradigms are developed, employed and practiced by European Wellness Centers (EWC) – a global network of institutions tied up by the concept of European Biological Wellness. Our philosophy does not support mechanistic approach to the patient but encourages holistic care, promotes therapies stimulating healing and regeneration, and puts wellness as a corner stone of the intended outcomes. Another two integral components of Biological Wellness are maximal safety of the therapeutic modalities and its compatibility with conventional medicine.
Therapeutic paradigms of European Wellness are built on the platform of classical medicine taught and practiced all over Europe. Years spent on gaining experience and collaborating with most prominent European doctors and precise selection of fine treatment modalities from certain Asian traditional medical systems allowed us to formulate a unique system of Biological Wellness that to our knowledge does not have analogues up to date. The core of European Biological Wellness contains principles of biological medicine, which states that the human body is inherently capable of self-healing, and these abilities depend on anatomical, physiological, mental and spiritual balance. Once any component of this integral system is compromised, the occurring imbalance results in the development of disease. While conventional medicine predominantly identifies and emphasizes on symptoms and certain links of pathogenesis, our way of biological wellness, addresses the underlying causes of disease and acts concurrently with any existing treatment, modulates and balances the entire organism and directs it to effective healing and recovery.
The main objective of the book is to offer to the medical community effective holistic diagnosis, detoxification, biological repair and rejuvenation based on the individual needs of the persons and taking into consideration the health status and medical conditions. The book also provides specialized Biological wellness, recovery, and performance enhancement programs for athletes,elderly people, individuals with various untreatable illnesses and congenital disorders with the purpose of improving their general condition and facilitating their primary treatment.
A book by Prof. Dr. Mike Chan and Dr. Dina Tulina
Published by Matador, Troubador.co.uk, London – Medical Research: ISBN 978-1-80313-118-4
Multiple sclerosis (MS) is a progressive neurological disease that affects millions of people worldwide. Currently, the causes of MS are still unclear and the cure of MS remains symptomatic, while the effectiveness of treatment varies widely among individuals. The clinical features and neurological defects derived from this progressive neurological disease are diverse since MS may affect the human central nervous system (CNS) at all levels from the brain to hen end of the spinal cord. Immunopathogenesis of MS involves many steps, including activation of peripheral leucocytes against putative CNS antigens, activated leucocytes with inflamed cerebral endothelial cells, the migration of activated lymphocytes and macrophages through the endothelium to the CNS environment, and further propagation of a massive immune response within the CNS, Such large-scale immune activation leads to loss of the myelin-oligodendrocyte complex. Various types of immune cells and mediators of the immune-inflammatory response actively contribute to the pathogenesis of MS. Genetic factors are also thought to play a central role in the development of most forms of MS. Axonal degeneration and neuronal loss are the core components of irreversible and permanent CNS atrophy and disability in MS.
This book provides a comprehensive overview of the current MS situation as researchers try to understand the process and develop treatments that can slow or stop the disease, possible repair the damage, alleviate specified symptoms, and improve the abilities of MS patients to function in everyday life. Various biological holistic approaches have been shown to slow disease progression in some patients, and the recovery rate of cellular mechanism in the brain and spinal cord has been accelerated, increasing the possibility of achieving complete balance of the disease state.
The panels review the background, focusing on novel strategies that are most likely to understand the biological mechanism of recovery and translate findings into alternative comprehensive approach to the MS management. The modality of such complementary therapies adds a new dimension, geared to further improvement in the management and sustain the acquired long-term results of MS. This books will necessary to MS researchers, research funder, healthcare advocate MS research and treatment, and interested patients and their families.
A book by Dr. Arseniy Trukhanov and Prof. Dr. Mike K.S. Chan
Published by EUROPEAN WELLNESS ACADEMY – Medical Research: ISBN 9781662930201, eISBN: 9781662930218
Library of Congress Control Number: 2022941479
This handbook focuses on the different aspects around the anti-aging, preventive and regenerative medicine. Discussion about the paradigm of ageing as well as the concepts of anti-aging medicine, its standards and technologies are highlighted in more than 20 chapters all written by international experts in regenerative medicine. Some of the topics covered in this book include:
- Ageing, aging and anti-aging: A Decalogue for anti-aging medicine
- Lessons from Sicilian centenarians for anti-aging medicine
- Molecular biomarkers and genetic aspects of aging
- Future of peptides in clinical practice
- Mitochondrial approaches in anti-aging medicine and in SARS-CoV2 infection
- Tissue-specific autoantibodies in preventive medicine
- Chronic stress as a psycho-neuro-immunological dysfunction
- Gut-associated immune system and its health implications
- Regenerative medicine with platelet-rich-plasma
- Alzheimer's disease: Preventive and anti-aging neurology
- Autistic spectrum disorder and mitochondrial medicine
- Integrative hormonal approach in anti-aging medicine
- Preventive cardiology and phlebology
- Aesthetic and anti-aging medicine
- Preventive ophthalmology
- Preventive oncology
- Nutrition in healthy aging
- Physical activity and fitness paradigms for anti-aging and longevity
All clinicians working in anti-aging medicine - as well as ageing people – should read this book. It will hopefully set the "Standard of anti-aging medicine" and thus will be a tool in planning the challenges we all will face caring the ageing patients and creating the preventive programs for them.
Published by EUROPEAN WELLNESS ACADEMY – Medical Research: ISBN: 9781662930140, eISBN: 9781662930157
Library of Congress Control Number: 2022941476
A new work from the authors of Stem Cells in Regenerative Medicine, Comprehensive Guide to Biological Medicine and Wellness, and Cell Membrane Therapy. A revolutionary discussion of contemporary scientific views on the role of the immune system in occurrence with age-related degenerative diseases such as cancer and autoimmune diseases. Immunotherapy options and medical indications for the use of various types of immunotherapeutic products are reviewed. Biological methods of immunotherapy are emphasized, i.e. transfer factors, thymic peptides, autologous vaccines, active specific immunotherapy, macrophage activating factors, et cetera. This book is backed by extensive literature reviews, references, and citations, as well as presentation of relevant clinical cases.
By Prof Dr Mike KS Chan, Prof. Dr. Michelle B.F. Wong, Dr Patricia Pan, Yvonne Chia, Clarice EA, Yee Hui Rong and Yenny Kenisi
Published by EUROPEAN WELLNESS ACADEMY – Medical Research: ISBN: 9781662930041, eISBN: 9781662928574
Library of Congress Control Number: 2022941169
The success of transplantation to treat human diseases has greatly increased the demand for organs and tissues. Xenotransplantation, the use of animals as donors, is viewed increasingly as a solution to this problem. The pig-to-NHP model has become the standard for preclinical studies of cell and tissue xenotransplantation prior to starting a clinical trial.
This is A Compilation of Cell and Tissue Xenotransplantation Studies (1838-2022): A Promising Approach for the Treatment of Diseases and a collection of reminiscences by surgeons and scientists who made significant research contributions toward achieving successful transplantation of animal cells and tissues into humans. It records the works of the world’s leading researchers in this field which will impact the future medical care of patients with diabetes, liver failure, neurodegenerative disorders, corneal blindness, etc.
It also provides a comprehensive overview of applications of cellular and tissue xenotransplantation for a range of diseases especially those that result from tissue loss or dysfunction. The importance of the decellularization technique in animal tissues and organs as implantable biomaterials in the field of regenerative medicine and tissue engineering is also highlighted.
Essential reading for physicians, scientists, and lay persons with an interest in xenotransplantation; those caring for patients with life-threatening diseases; and also those interested in understanding the potential of genetic and tissue engineering in science and medicine. This book charts a historical record of the research which has contributed to the advancement of medicine called “the next great medical revolution.” Many believe we are on the threshold of clinical trials using genetically modified animals as organ donors. If successful, the benefits of clinical xenotransplantation will be enormous and will represent one of the greatest advances in modern medicine.
By Prof Dr Mike KS Chan, Prof. Dr. Michelle B.F. Wong, Dr Patricia Pan, Dr Dina Tulina, Yvonne Chia, Clarice EA, Yee Hui Rong and Yenny Kenisi.
Published by EUROPEAN WELLNESS ACADEMY – Medical Research: ISBN: 9781662930010, eISBN: 9781662930027
Library of Congress Control Number: 2022941736
To date, transfer factors hold promise as one of the most exciting discovery in immunology and disease prevention. As the 21st century unfolds, these small molecules represent an important key to human health and well-being. Transfer factors are material present in dialysable leukocyte extracts capable of transferring cell-mediated immunity to pathogens. Transfer factors from one immune donor can be introduced into a non-immune recipient, potentially delivering an improved ability to fight threats to the recipient’s health. Similar to vaccines, transfer factors are prophylactic when administered prior to exposure to a pathogen.
This book is an overview of basic immunology and the concept of transfer factors derived from past and current scientific publications. In this book, the properties, mechanism of action, and clinical applications of transfer factors are described. Since their discovery, evidence suggests transfer factors play an important role as immune modulators in treating diseases associated with the defective function of cell-mediated immunity such as cancer, infectious diseases, etc.
The MF Plus Super Transfer Factor is then introduced including its function, characteristics, course, mode of administration, and advantages. The conclusion compiles research papers of transfer factor from years 2009 to 2020.
This book will interest researchers and scientists in fields such as immunology, molecular medicine, biomedicine, immunotherapy, pathology, microbiology, and oncology.
Stem Cells, Peptides & Immunotherapy in Regenerative Medicine For Animals
Dawn of a New Medicine: Stem Cells & Cell Therapy
Multiple Sclerosis: Practical Comprehensive Essentials
Obesity: Current Holistic and Bioregenerative Therapy
Metabolic Syndrome: Current Holistic and Bioregenerative Therapy
Diabetes: Current Holistic and Bioregenerative Therapy
Obesity, Metabolic Syndrome, and Diabetes: The State of Art Bioregenerative Medicine
Autistic Spectrum Disorders: The State of Art Bioregenerative Medicine
A Compilation Of Cell And Tissue Xenotransplantation Studies (1838-2020) A Promising Approach for The Treatment Disease
Transfer Factors: Properties, Mechanism of Action and its Clinical Applications